Celldex to Present at Upcoming April 2026 Investor Conference
Tuesday, April 14, 2026 1 min read
Key Takeaway: Celldex (NASDAQ:CLDX) will participate in a fireside chat at H.C. Wainwright's 4th Annual Inflammatory Skin Disease Virtual Conference on April 14, 2026. The event will be accessible via webcast, with replays available for 90 days. This participation highlights Celldex's commitment to engaging with investors and discussing its advancements in immunology.
Market Sentiment Analysis
POSITIVE FACTORS
Celldex is actively participating in industry conferences.
The company is focused on innovative therapies in immunology.
The event provides an opportunity for investor engagement.
Full Press Release Details
HAMPTON, N.J., April 13, 2026(GLOBE NEWSWIRE)-- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at H.C. Wainwright’s 4th Annual Inflammatory Skin Disease Virtual Conference on Tuesday, April 14 at 3:30 pm ET.
The webcast of the presentations will be available on the "Events & Presentations" page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event.
About CelldexCelldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.Visitwww.celldex.com.
Company ContactSarah CavanaughSenior Vice President, Corporate Affairs & Administration(508) 864-8337scavanaugh@celldex.com